Aims: To assess and compare costs associated with diabetes and lesser degrees of glucose intolerance in Australia. Methods: The Australian Diabetes, Obesity and Lifestyle study collected data on the use of health services and health related expenditure in 2004-2005. Complications data were collected through physical examination and biochemical tests or questionnaire. Data were available on 6101 participants. Age- and sex-adjusted direct healthcare costs, direct non-healthcare costs and government subsidies were estimated according to glucose tolerance status. Results: Annual direct per person costs were A$1898 for those with normal glucose tolerance to A$4390 for those with known diabetes. Costs were substantially higher in people with diab...
Aims: To compare the diabetes prevention impact and cost of several screening scenarios for diabetes...
OBJECTIVE—To determine the population-based prevalence of diabetes and other categories of glucose i...
BACKGROUND: Diabetes mellitus in hospital inpatients is most commonly present as a comorbidity rathe...
© 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group. Aims: To assess and compare ...
Objectives: To estimate the incidence of disease and annual disease-specific hospital costs for peop...
Diabetes Mellitus is estimated to affect around one million Australians, a number that is likely to ...
Objectives: To estimate Australian health-care costs in the year of first occurrence and subsequent ...
Aims To quantify the incremental direct medical costs in people with diabetes...
The WHO Global report on diabetes (2016) highlights the scale of diabetes as an important public hea...
The cost of diabetes to the health care system is significant and has been well documented. Less wel...
Aims: To compare the diabetes prevention impact and cost of several screening scenarios for diabetes...
OBJECTIVE—To determine the population-based prevalence of diabetes and other categories of glu...
This ABS article provides a brief overview of the prevalence, comorbidity and mortality, risk factor...
Objective: To determine the population-based prevalence of diabetes and other categories of glucose ...
OBJECTIVE - This national, population-based study reports diabetes incidence based on oral glucose t...
Aims: To compare the diabetes prevention impact and cost of several screening scenarios for diabetes...
OBJECTIVE—To determine the population-based prevalence of diabetes and other categories of glucose i...
BACKGROUND: Diabetes mellitus in hospital inpatients is most commonly present as a comorbidity rathe...
© 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group. Aims: To assess and compare ...
Objectives: To estimate the incidence of disease and annual disease-specific hospital costs for peop...
Diabetes Mellitus is estimated to affect around one million Australians, a number that is likely to ...
Objectives: To estimate Australian health-care costs in the year of first occurrence and subsequent ...
Aims To quantify the incremental direct medical costs in people with diabetes...
The WHO Global report on diabetes (2016) highlights the scale of diabetes as an important public hea...
The cost of diabetes to the health care system is significant and has been well documented. Less wel...
Aims: To compare the diabetes prevention impact and cost of several screening scenarios for diabetes...
OBJECTIVE—To determine the population-based prevalence of diabetes and other categories of glu...
This ABS article provides a brief overview of the prevalence, comorbidity and mortality, risk factor...
Objective: To determine the population-based prevalence of diabetes and other categories of glucose ...
OBJECTIVE - This national, population-based study reports diabetes incidence based on oral glucose t...
Aims: To compare the diabetes prevention impact and cost of several screening scenarios for diabetes...
OBJECTIVE—To determine the population-based prevalence of diabetes and other categories of glucose i...
BACKGROUND: Diabetes mellitus in hospital inpatients is most commonly present as a comorbidity rathe...